Pancreatic cancer is one of the most dangerous cancers in the world. Doctors often call it a “silent” disease because many people do not notice symptoms until the cancer has already spread.
By the time it is found, treatment options are often limited. Because of this, pancreatic cancer has one of the lowest survival rates among major cancers.
Experts believe the disease could become the second leading cause of cancer-related deaths in the United States by 2030. Scientists are now working hard to find ways to detect pancreatic cancer earlier, when treatment has a better chance of success.
A new study from Johns Hopkins Medicine may offer an important clue. Researchers discovered that a small widening of the pancreatic duct may be an early warning sign of pancreatic cancer in people who are already considered high-risk.
The pancreatic duct is a tiny tube inside the pancreas. Its job is to carry digestive juices from the pancreas to the small intestine to help break down food. Normally, this duct is narrow.
But researchers found that even a slight enlargement may signal that dangerous changes are happening inside the pancreas long before a tumor can actually be seen on scans.
The study was published in the journal Gastro Hep Advances in November 2025. Scientists say this finding may help doctors detect pancreatic cancer much earlier than before.
The research was led by Dr. Marcia Irene Canto from the Johns Hopkins University School of Medicine. She explained that doctors have traditionally looked for visible tumors during scans, but this new research shows that structural changes in the pancreas may appear first.
Dr. Canto said the widening of the pancreatic duct could act like an early alarm signal, even when no clear cancer mass can be detected yet. This may give doctors more time to monitor patients closely and begin treatment earlier if needed.
The study is part of the long-running Cancer of the Pancreas Screening program, also known as CAPS. This program began in 1998 and follows people who have a higher chance of developing pancreatic cancer because of family history or inherited gene mutations.
Some people are considered high-risk because several close family members have had pancreatic cancer. Others may carry genetic mutations that increase their risk. These patients often receive regular screening because early detection is especially important for them.
In the latest study, researchers followed 641 high-risk participants. The patients regularly underwent MRI scans and endoscopic ultrasound exams so doctors could carefully monitor changes in the pancreas over time.
The scientists discovered that people with pancreatic ducts wider than 4 millimeters were more likely to develop dangerous tissue changes called high-grade dysplasia, which can later turn into cancer.
These patients were about 2.6 times more likely to develop pancreatic cancer compared to people without duct enlargement.
The risk became even higher in people who also had several pancreatic cysts. Researchers found that patients with duct enlargement and three or more cysts faced an especially increased cancer risk.
Out of the 641 participants, 97 people showed pancreatic duct enlargement even though no visible tumor was blocking the duct. Within around two years, 10 of these individuals were diagnosed with pancreatic cancer or serious pre-cancerous changes.
The study also showed that the risk increased over time. People with duct enlargement had about a 16% chance of developing pancreatic cancer within five years and a 26% chance within ten years.
Importantly, many of these cancers were discovered at an earlier stage than usual. This is important because pancreatic cancer is much easier to treat before it spreads to other organs.
Researchers say this finding may change how doctors monitor high-risk patients. Instead of waiting for a visible tumor to appear, doctors may begin paying closer attention to subtle changes in the pancreatic duct.
Dr. Canto explained that even the best imaging technology may not immediately show a small cancer tumor.
However, doctors may still notice the structural changes caused by the cancer process. This could allow them to act sooner by increasing monitoring, ordering additional scans, or considering surgery before the disease advances.
The researchers also pointed out that pancreatic duct enlargement is sometimes found accidentally during imaging tests done for unrelated health problems, such as kidney stones or stomach pain. This means doctors should pay careful attention if this abnormality appears, especially in patients with family history or genetic risk.
Looking ahead, the Johns Hopkins team hopes to use artificial intelligence to improve early detection even further. They plan to train computer systems to study imaging scans and medical records to identify subtle warning signs that humans might miss.
Scientists believe artificial intelligence could help predict which patients are most likely to develop pancreatic cancer based on tiny changes in the pancreas over time.
Although more research is still needed, experts say this discovery is an important step forward. Pancreatic cancer has long been difficult to catch early, but identifying warning signs like pancreatic duct enlargement could give doctors a valuable new tool.
If future studies confirm these findings, more patients may one day have a chance to detect pancreatic cancer before it becomes life-threatening. Earlier diagnosis could lead to better treatment, longer survival, and more hope for families facing this deadly disease.
If you care about cancer, please read studies that a low-carb diet could increase overall cancer risk, and vitamin D supplements could strongly reduce cancer death.
For more information about health, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing higher intake of dairy foods linked to higher prostate cancer risk.
The study was published in Gastro Hep Advances.
Copyright © 2026 Knowridge Science Report. All rights reserved.
